A major discovery in cancer investigation is emerging with the use of mini-antibodies to reactivate mutated p53. This essential tumor suppressor protein is frequently disabled in several forms of cancer, leading https://social-medialink.com/story7017510/nanobodies-revive-the-p53-protein-the-new-approach-for-malignant-management